Terms ending in 2039
Every in-force patent on H. Lundbeck A/S's record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,535,611 | Pyrazolo[3,4-b]pyridines and Imidazo[1,5-b]pyridazines as PDE1 Inhibitors In force · High confidence | H. Lundbeck A/S | In force | High confidence | |
| US 11,549,871 | Apparatus and Method for Isolation And/Or Preparation of Particles In force · High confidence | H. Lundbeck A/S | In force | High confidence | |
| US 11,535,600 | Prodrugs of 4-((1R, 3S)-6-Chloro-3-Phenyl-2,3-Dihydro-1H-INDEN-1-Y)-1-,2,2-Trimethylpiperazine and 4-((1R,3S)-6-Chloro-3-(PHENYL-D5)-2,3-Dihydro-1H-INDEN-1YL)-2,2-Dimethyl-1 (METHYL-D3)PIPERAZINE In force · High confidence | H. Lundbeck A/S | In force | High confidence | |
| US 12,071,416 | Prodrugs of 4- ( (1R, 3S) -6-Chloro-3-Phenyl-2, 3-Dihydro-1H-INDEN-1-YL) -1,2, 2-Trimethylpiperazine and 4- ( (1R, 3S)-6-Chloro-3- (PHENYL-D5) -2, 3-Dihydro-1H-INDEN-1-YL) -2, 2-Dimethyl-1 (METHYL-D3) Piperazine In force · Medium confidence | H. Lundbeck A/S | In force | Medium confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.